Iridex Reports Q4 Net Loss of $200K, Sets FY Revenue Outlook at $51-53M
Summary
IRIDEX Corporation announced its fourth-quarter results, reporting revenue of $14.7 million and a net loss of $200 thousand. The company also provided a full-year revenue outlook of $51-53 million. These financial figures, particularly the net loss, are crucial for investors to assess the company's recent performance and future trajectory. This earnings update is a distinct event from the recent 8-K filing regarding a new corporate headquarters lease. Traders will closely monitor how these results align with market expectations and the company's ability to meet its forward guidance.
At the time of this announcement, IRIX was trading at $1.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $23.2M. The 52-week trading range was $0.79 to $1.65. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.